Skip to content
Clinical Trial Events
ISPOR Europe 2026

Panel Access and Pricing track

Most Favored Nation Pricing: Will International Price Alignment Improve Affordability or Restrict Access to Innovation? Insights from Central and Eastern Europe

Tue, Nov 10, 2026 · 4:45–5:45 PM CET Hall F2, Level 0, Austria Center Vienna

About this session

**Issue** Most Favoured Nation (MFN) pricing policies and international price alignment mechanisms are increasingly shaping pharmaceutical pricing and reimbursement discussions worldwide. Governments view these approaches as tools to improve affordability and strengthen negotiating power.

Speakers